Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Vifor Pharma grants Zeria license to develop and market Veltassa in Japan

March 29, 2018

Bardoxolone methyl granted Sakigake designation in Japan

March 28, 2018

Vitaros end-of-review meeting scheduled by FDA

March 27, 2018

Phase III efficacy and safety data reported for vibegron in overactive bladder

March 27, 2018

Lokelma receives E.U. approval for hyperkalemia

March 23, 2018

Boston Scientific to acquire NxThera

March 22, 2018

Eli Lilly discovers novel PDE1 inhibitors

March 22, 2018

Mereo announces topline phase IIb results for BGS-649 to treat hypogonadotropic hypogonadism

March 19, 2018

OxThera initiates phase III study of Oxabact in primary hyperoxaluria

March 15, 2018

Solifenacin oral suspension for pediatric patients approved in Europe

March 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...